Literature DB >> 10727651

The roles of gender, the menopause and hormone replacement on cardiovascular function.

C S Hayward1, R P Kelly, P Collins.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10727651     DOI: 10.1016/s0008-6363(00)00005-5

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  81 in total

1.  Cardiac hypertrophy and oxidative stress: a leap of faith or stark reality?

Authors:  D Lang
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

Review 2.  Clinical implications of physiological changes in the aging heart.

Authors:  K G Pugh; J Y Wei
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Mechanism of cardioprotection: what can we learn from females?

Authors:  Elizabeth Murphy; Claudia Lagranha; Anne Deschamps; Mark Kohr; Tiffany Nguyen; Renee Wong; Junhui Sun; Charles Steenbergen
Journal:  Pediatr Cardiol       Date:  2011-01-29       Impact factor: 1.655

Review 4.  Cardiac mast cells: the centrepiece in adverse myocardial remodelling.

Authors:  Scott P Levick; Giselle C Meléndez; Eric Plante; Jennifer L McLarty; Gregory L Brower; Joseph S Janicki
Journal:  Cardiovasc Res       Date:  2010-08-24       Impact factor: 10.787

5.  Characterization of the sex-dependent myocardial S-nitrosothiol proteome.

Authors:  Qin Shao; Jonathan Fallica; Kevin M Casin; Elizabeth Murphy; Charles Steenbergen; Mark J Kohr
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-12-23       Impact factor: 4.733

6.  Prevalence of cardiovascular risk factors among rural population of elderly in Wardha district.

Authors:  Rajnish Joshi; Bharti Taksande; Shri Prakash Kalantri; Ulhas Narayan Jajoo; Rajeev Gupta
Journal:  J Cardiovasc Dis Res       Date:  2013-06-19

7.  Oestrogen confers cardioprotection by suppressing Ca2+/calmodulin-dependent protein kinase II.

Authors:  Y Ma; W T Cheng; S Wu; T M Wong
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

8.  Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.

Authors:  Cameron Donaldson; Sarah Eder; Corey Baker; Mark J Aronovitz; Alexandra Dabreo Weiss; Monica Hall-Porter; Feng Wang; Adam Ackerman; Richard H Karas; Jeffery D Molkentin; Richard D Patten
Journal:  Circ Res       Date:  2008-12-12       Impact factor: 17.367

9.  17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload.

Authors:  Richard D Patten; Isaac Pourati; Mark J Aronovitz; Alawi Alsheikh-Ali; Sarah Eder; Thomas Force; Michael E Mendelsohn; Richard H Karas
Journal:  J Card Fail       Date:  2008-04       Impact factor: 5.712

Review 10.  Estrogen and the female heart.

Authors:  A A Knowlton; D H Korzick
Journal:  Mol Cell Endocrinol       Date:  2014-01-22       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.